Free Trial

Evoke (LON:EVOK) Trading 17.2% Higher - Still a Buy?

Evoke logo with Consumer Cyclical background

Evoke plc (LON:EVOK - Get Free Report)'s stock price was up 17.2% during trading on Tuesday . The company traded as high as GBX 45.90 ($0.60) and last traded at GBX 44.30 ($0.58). Approximately 3,500,189 shares traded hands during mid-day trading, an increase of 35% from the average daily volume of 2,588,063 shares. The stock had previously closed at GBX 37.80 ($0.49).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reissued a "buy" rating and set a GBX 140 ($1.83) price target on shares of Evoke in a report on Monday, December 16th.

Get Our Latest Stock Report on EVOK

Evoke Stock Up 2.4 %

The stock has a fifty day moving average price of GBX 62.59 and a 200-day moving average price of GBX 62.11. The firm has a market cap of £212.29 million, a price-to-earnings ratio of -1.19 and a beta of 0.84.

Evoke (LON:EVOK - Get Free Report) last announced its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. As a group, research analysts expect that Evoke plc will post 12.7648305 earnings per share for the current year.

Insider Activity at Evoke

In other Evoke news, insider Andrea Gisle Joosen acquired 14,572 shares of the business's stock in a transaction on Tuesday, January 28th. The stock was purchased at an average price of GBX 70 ($0.92) per share, for a total transaction of £10,200.40 ($13,346.07). Also, insider Jonathan (Jon) Mendelsohn bought 200,000 shares of the firm's stock in a transaction on Monday, March 31st. The shares were bought at an average price of GBX 48 ($0.63) per share, for a total transaction of £96,000 ($125,605.13). 27.00% of the stock is owned by insiders.

About Evoke

(Get Free Report)

Featured Stories

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines